Haesuk Park

Haesuk Park, Ph.D.

Associate Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6261
Business Email: hpark@cop.ufl.edu

About Haesuk Park

Haesuk Park, Ph.D., is an Associate Professor in the Department of Pharmaceutical Outcomes and Policy. She received her Bachelor and Master in Pharmacy from South Korea, and her Ph.D. at The University of Texas at Austin, College of Pharmacy, Health Outcomes & Pharmacy Practice. Her research centers on economic and health outcomes studies of medications and pharmaceutical care services as well as policy associated with the use of pharmaceuticals. She is passionate about investigating questions related to health policy in vulnerable populations and, particularly, how a policy affects access to care, the quality and cost of health care, and ultimately health outcomes.

Research Profile

In recent years, clinical focus of Dr. Park’s research has centered on patients with hepatitis C virus (HCV) infection, a research area with growing intensity and breadth due to the increasing awareness of the disease burden and the continuing development of new treatments. In 2018, Park received a 5-year NIH/National Institute on Drug Abuse (NIDA) K01 to build a research program in the area of HCV and health policy for individuals with substance use disorders. Currently, she also collaborated on a NIH/NHLBI R01 project to evaluate the impact of the pharmacist-led telehealthcare medication therapy management to change health outcomes in adolescents and young adults with asthma (MATCH).

Her research has received a number of awards and recognition by the professional community such as the Best New Investigator Presentation Award at the International Society for Pharmaceutical Outcomes Research (ISPOR), Best Paper Award in the Economic, Social & Administrative Sciences at the American Pharmacists Association (APhA) Annual Meeting, and the 2015 University of Florida Excellence Award for Assistant Professors. Her research interests include Pharmacoeconomics and health policy research, economic and health outcomes evaluation and meta-analysis.



Apr 2019 ACTIVE
A Behavioral Economic Intervention to Reduce Marijuana Use in Truant Youth
May 2018 ACTIVE
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations
NATL INST OF HLTH NIDA · Principal Investigator
May 2018 ACTIVE
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)
NEMOURS CHILDRENS CLINIC · Principal Investigator
Jun 2016 – Jun 2018
Work Order No. US201601
PROTEUS DIGITAL HEALTH INC · Principal Investigator
Apr 2014 – Mar 2017
HCV Quality-Adjusted Cost of Care (Work Order #5)
GILEAD SCIENCES · Principal Investigator

Contact Details

(352) 273-6261

Recent news

UF research study examines the impact of hepatitis C virus treatment on risk of non-hepatic cancers among hepatitis C virus infected patients

Wei “Vivian” Wang, Ph.D., in the department of pharmaceutical outcomes and policy and Haesuk Park, Ph.D., an associate professor in the department, led the study.

International Day of Women in Science

The University of Florida College of Pharmacy celebrates women advancing the pharmaceutical sciences during the fifth International Day of Women and Girls in Science on Feb. 11. Five female faculty…

Congratulations to Dr. Haesuk Park on her tenure award and promotion

Park’s tenure and promotion to associate professor became official on July 1.

NIH grant will fund study of telehealth for adolescents and young adults with asthma

UF College of Pharmacy researchers will investigate whether telehealth will improve asthma medication adherence and health outcomes.